pancreatic cancer
Breakthrough Genomics Partners With PRECEDE Pancreatic Cancer Consortium
The PRECEDE Consortium will help with the clinical evaluation of Breakthrough's blood-based pancreatic cancer early detection test.
The test assigns a pancreatic cancer subtype based on the expression of 16 genes measured using an array.
Foundation Medicine, Merus to Develop CDx for Cancer Drug to Treat Patients With NRG1 Fusions
The companies will use Foundation's RNA sequencing platform to develop a companion diagnostic for Merus' bispecific antibody zenocutuzumab.
Biological Dynamics Shutters; Successor Firm to Advance Exosome Platform
The company closed its doors June 30, according to a Worker Adjustment and Retraining Notification filed in California.
The company's PreveCol test uses molecular biomarkers and clinical features to detect colorectal cancer and precancerous lesions from blood samples.
Feb 14, 2024
Oct 11, 2022